Antibodies used for immunofluorescence staining on a melanoma tissue microarray (TMA).</p
ABSTRACT: Drug resistance is a major obstacle in melanoma treatment. Recognition of specific resista...
Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neit...
Additional file 7: Table S6. Pathway analysis of protein targets of toxicity-associated antibodies. ...
Characteristics and clinical baseline parameters of melanoma patients in the study.</p
Differentially expressed proteins (DEPs) in NR of the discovery serum and tumor cell cohorts.</p
Statistical analysis of baseline clinical parameters in the serum discovery cohort (n=56).</p
Statistical analysis of baseline clinical parameters in the independent Zurich serum validation coho...
Differentially expressed proteins (DEPs) and functional annotation of NR proteomes based on GO term ...
Results of the Wilcoxon rank sum tests, dependent variable = first component of the PCA.</p
Immunotherapy improves the survival of patients with advanced melanoma, 40% of whom become long-term...
Background Immune checkpoint inhibitors (ICIs) have significantly improved the outcome in metastatic...
Additional file 2: Table S2. Patient characteristics for reproducibility cohort (n = 10). Summary of...
Formalin‐fixed paraffin embedded (FFPE) clinical tissues represent an abundant and unique resource f...
BACKGROUND: Blood-based proteomic profiling may aid and expand our understanding of diseases and the...
Abstract Immune checkpoint inhibitors (ICIs) such as pembrolizumab have revolutionized the treatment...
ABSTRACT: Drug resistance is a major obstacle in melanoma treatment. Recognition of specific resista...
Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neit...
Additional file 7: Table S6. Pathway analysis of protein targets of toxicity-associated antibodies. ...
Characteristics and clinical baseline parameters of melanoma patients in the study.</p
Differentially expressed proteins (DEPs) in NR of the discovery serum and tumor cell cohorts.</p
Statistical analysis of baseline clinical parameters in the serum discovery cohort (n=56).</p
Statistical analysis of baseline clinical parameters in the independent Zurich serum validation coho...
Differentially expressed proteins (DEPs) and functional annotation of NR proteomes based on GO term ...
Results of the Wilcoxon rank sum tests, dependent variable = first component of the PCA.</p
Immunotherapy improves the survival of patients with advanced melanoma, 40% of whom become long-term...
Background Immune checkpoint inhibitors (ICIs) have significantly improved the outcome in metastatic...
Additional file 2: Table S2. Patient characteristics for reproducibility cohort (n = 10). Summary of...
Formalin‐fixed paraffin embedded (FFPE) clinical tissues represent an abundant and unique resource f...
BACKGROUND: Blood-based proteomic profiling may aid and expand our understanding of diseases and the...
Abstract Immune checkpoint inhibitors (ICIs) such as pembrolizumab have revolutionized the treatment...
ABSTRACT: Drug resistance is a major obstacle in melanoma treatment. Recognition of specific resista...
Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neit...
Additional file 7: Table S6. Pathway analysis of protein targets of toxicity-associated antibodies. ...